This, together with the high KIF11 mRNA expression in SCLC tissues (Figure 1A), suggests that most SCLC tumors would be sensitive to KIF11 inhibitors, resulting in decreased viability. This evidence concerns the gene KIF11 and small cell lung carcinoma.